Nicolas Santi

Nicolas Santi, MD, FRCPC, DRCPSC is an Assistant Professor with a focus on infectious diseases, immunology, and HIV research. His work spans clinical practice improvements, virological investigations, and immune system dynamics in chronic infections. Current research emphasizes SARS-CoV-2 antibody responses, HIV pathogenesis, and extracellular vesicle-mediated immune modulation. He has contributed to large-scale studies on antiviral therapies (e.g., remdesivir, sotrovimab) and pandemic response strategies in healthcare settings. Key collaborations include the WHO Solidarity Trial and the Canadian Treatments for COVID-19 (CATCO) initiative. His studies often bridge clinical outcomes with molecular mechanisms, particularly in immune cell dysfunction and recovery patterns post-treatment.